Skip to main content
. 2019 Mar 19;104(11):2249–2257. doi: 10.3324/haematol.2018.204891

Table 3B.

Seven-year progression-free and overall survival rates after 36 months of maintenance therapy according to measurable residual disease group.

graphic file with name 1042249.tab3b.jpg